Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Abbott Laboratories (ABT) reported revenue of $12.59B in Q2 2026, with Diagnostic Products its largest revenue segment at 40%.
Abbott sells medical devices (FreeStyle Libre diabetes sensors, electrophysiology, structural heart), diagnostics (core lab plus Exact Sciences cancer tests after the March 2026 close), pediatric and adult nutrition, and branded generic medicines outside the U.S.
Abbott Laboratories (ABT) is a Health Care Equipment company. Abbott sells medical devices (FreeStyle Libre diabetes sensors, electrophysiology, structural heart), diagnostics (core lab plus Exact Sciences cancer tests after the March 2026 close), pediatric and adult nutrition, and branded generic medicines outside the U.S. It was founded in 1888, is headquartered in Abbott Park, Illinois and employs about 115,000 people.
As of 2026-Q2, Abbott Laboratories's revenue breaks down across Diagnostic Products (40%), Medical Devices (37%), Nutritional Products (14%), Established Pharmaceutical Products (10%). See the revenue-by-segment chart for the full mix.
Track Abbott Laboratories's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated October 10, 2026.
Sterling groups Abbott Laboratories in the Healthcare industry, alongside Baxter International (BAX), Becton Dickinson (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), GE HealthCare (GEHC) and Idexx Laboratories (IDXX). Sterling also tracks it in the GLP-1 industry.
If you are researching Abbott Laboratories, also look at Baxter International (BAX), Becton Dickinson (BDX) and Boston Scientific (BSX). You can compare all of them side by side or browse the full Healthcare industry on Sterling.
Q3 2016-Q2 2026
Q3 2016-Q2 2026